BiotechTube
Home/Nacuity Pharmaceuticals/Halden Conner
HC

Halden Conner

Chairman, CEO, Co-Founder

Nacuity Pharmaceuticals

Therapeutic Areas

OphthalmologyRare Diseases

Nacuity Pharmaceuticals Pipeline

DrugIndicationPhase
NPI-001Retinitis PigmentosaPhase 2/3

Leadership Team at Nacuity Pharmaceuticals

GM
G. Michael Wall, PhD
SVP, Chief Scientific Officer
JR
Jami R. Kern, MBA, PhD
SVP, Chief Clinical Officer
LA
Lee Anderson, MD
Ophthalmologist in Residence
CL
Charles Lieser, JD, CPA
CFO
View full Nacuity Pharmaceuticals profile